XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake

Corroborated by 2 sources from 2 publishers

globalhealth1d ago

TL;DR

Reports differ across sources; according to investing.com, xTL Biopharmaceuticals to acquire Psyga Bio for 40% stake.

Sources